| Product |
Cat# |
IFU |
Incubation |
Stand.Range/Sensitivity |
Specimen |
Type |
Method |
Units |
| PSA, Total (Prostate Specific Antigen) |
CLA4657 |
IFU |
30 / 30 / 10 - 15 min. |
0.005 - 100 ng/ml /// 0.002 ng/ml |
50 ul serum |
quantitative |
MTPL |
96 wells |
| TM-CA 72-4 |
CLA4730 |
IFU |
|
|
|
quantitative |
MTPL |
96 wells |
| TM-CYRFRA 21-1 |
CLA4731 |
IFU |
30 min. |
3 - 50 ng/ml /// 0.03 ng/ml |
50 ul serum, heparin plasma |
qualitative |
MTPL |
96 wells |
| CA 125 (Ovarian Cancer) Antigen |
EIA1472 |
IFU |
3 hrs. at 37 C. |
5 U/ml |
serum |
quantitative |
MTPL |
96 wells |
| CA 15-3 (Breast Cancer) Antigen (BCA) |
EIA1473 |
IFU |
120 min. at 37 C. |
5 U/ml |
serum |
quantitative |
MTPL |
96 wells |
| CA 19-9 (Gastrointestinal Cancer) Antigen (GCA) |
EIA1474 |
IFU |
120 min. at 37 C. |
5 U/ml |
serum |
quantitative |
MTPL |
96 wells |
| PAP (Prostatic Acid Phosphate) |
EIA1566 |
IFU |
40 min at RT |
1-30 ng/ml |
serum |
quantitative |
MTPL |
96 wells |
| PSA free |
EIA1792 |
IFU |
2 hrs. at RT |
0.05 ng/ml |
serum |
quantitative |
MTPL |
96 wells |
| CEA |
EIA1868 |
IFU |
60 / 15 min. |
0 - 100 ng/ml // 0.44 ng/ml |
50 ul serum / plasma |
quantitative |
MTPL |
96 wells |
| CEA |
EIA1871 |
IFU |
80 min. at RT |
1.0 ng/ml |
serum |
quantitative |
MTPL |
96 wells |
| NSE (Neuron specific Enolase) (controls to be ordered extra EIA4458) |
EIA2353 |
IFU |
|
|
|
quantitative |
MTPL |
96 wells |
| TPS (CYK18) (Tissue Polypeptide Specific Ag) (Cytokeratin) Elisa |
EIA2354 |
IFU |
|
|
|
quantitative |
MTPL |
96 wells |
| UBC (Urinary Bladder Cancer) Elisa |
EIA2355 |
IFU |
|
|
urine |
quantitative |
MTPL |
96 wells |
| PSA total |
EIA3719 |
IFU |
1.5 hrs |
1.56 - 25 ng/ml / 0.5 ng/ml |
25 ul |
quantitative |
MTPL |
96 wells |
| PAP Complex (Plasmin alpha-2 Antiplasmin Complex) |
EIA3763 |
IFU |
20'/20'/15' |
50 - 5000 ug/l / 50 ug/l |
plasma 50 ul |
quantitative |
MTPL |
192 wells |
| PSA free |
EIA4189 |
IFU |
60/60/15 min |
0.75 - 12 ng/ml / 0.1 nng/ml |
25ul serum |
quantitative |
MTPL |
96 wells |
| NSE |
EIA4424 |
IFU |
60 / 30 min |
5 - 200 ug/L // 1ug/L |
25 uL serum |
quantitative |
MTPL |
96 wells |
| NSE Elisa (controls included) |
EIA4610 |
IFU |
60 / 15 min |
4 - 100 ng/mL // 4 ng/mL. |
25 uL serum |
quantitative |
MTPL |
96 wells |
| TM-CYFRA 21-1 ELISA |
EIA5070 |
IFU |
60 / 15 min |
3 - 50 ng/ml /// 0.15 ng/ml |
50 ul serum, plasma |
quantitative |
MTPL |
96 wells |
| Cyr 61 Elisa (CCN1) |
EIA5108 |
IFU |
120 / 30 / 15 min |
40 - 1000 pg/ml /// 19.4 pg/ml |
50 ul serum, plasma (EDTA, Hepar |
quantitative |
MTPL |
96 wells |
| Cripto-1 Elisa |
EIA5109 |
IFU |
180 / 30 / 20 min. |
50 - 800 pg/ml /// 8.4 pg/ml |
50 ul serum |
quantitative |
MTPL |
96 wells |
| PSA semiquantitative (cassette) (min. 100 tests) |
RAP3539 |
IFU |
|
|
|
semiquantitative |
cassette |
each |
| Occult Detect |
RAP4236 |
IFU |
5 - 10 min. |
qualitative // 50 ng hHb/ml |
stool |
qualitative |
cassette |
20 cass. |
| Occult Detect Eco-Pro Rapid Test (dipstick) (min 10 kits) |
RAP4721 |
|
10 min |
- /// 50 ng/ml Haemoglobin |
stool |
quantitative |
dipstick |
25 tests |
| Occult Detect Advanced Rapid Test (cassette) (min 10 kits) |
RAP4723 |
|
8 min. |
- // 40 ng/ml Hemoglobin |
stool |
qualitative |
cassette |
12 cass |